🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ADHD Remote Technology and ADHD Transition: Predicting and Preventing Negative Outcomes

Recruitingn/aAges 16 Years - 17 YearsAllKing's College London
NCT07228650 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental condition affecting 5.9% of young people. Late adolescence can be a particularly challenging period for young people with ADHD, with major life transitions, new demands and increased expectations. This vulnerable phase also coincides with the transition from child and adolescent mental health care to adult ADHD services, where new UK data show that most young people with ADHD do not successfully transfer to adult services. Therefore, many young people with ADHD do not receive appropriate interventions at a time when they may need them most. Opportunities for intervention are currently not fully realised due to both the young people's disengagement from clinical services and our limited understanding of real-world targets for more holistic interventions. The current study seeks to address these needs using remo

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosis of DSM-5 ADHD * Aged 16-17 * Able to give informed consent for participation * Willing and able to complete self-reported assessments via smartphone * Willing to use either their own compatible Android phone or a study Android - phone as their only smartphone during the data collection period * Willing to wear the wearable device during the data collection period Exclusion criteria * Psychosis, currently experiencing a major depressive episode, mania, drug dependence in the last six months, or a major neurological disorder. * Recent contact with psychiatric acute care (admission, crisis team or liaison team (A\&E) in the last six months * Any other major medical disease which might impact upon the patient's ability to participate in normal daily activities (e.g., due to hospitalisations) * Pregnancy * IQ \< 70 Informant Inclusion Criteria: * A parent or guardian, as chosen by the participant with ADHD * Aged 18 or over * Willing and able to complete web-based questionnaires regarding the participant with ADHD
💊

What it tests

  • Not listed
📍

Where

1 site
King's College London
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy